[
  {
    "ts": "2026-01-23T10:12:43+00:00",
    "headline": "How Regeneron’s Broader Biologics Pipeline And Capital Return Focus At Regeneron Pharmaceuticals (REGN) Has Changed Its Investment Story",
    "summary": "Regeneron Pharmaceuticals has recently drawn renewed attention as investment funds, Wall Street analysts, and industry observers highlight its broad biologics pipeline, disciplined capital allocation, and avoidance of large acquisitions, alongside ongoing initiatives such as its long-term US$100 million sponsorship of the Regeneron Science Talent Search. What stands out is how investors increasingly emphasize the value of Regeneron’s pipeline beyond flagship products, viewing its focus on...",
    "url": "https://finance.yahoo.com/news/regeneron-broader-biologics-pipeline-capital-101243662.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "b9449e1b-1769-3ec1-b8a5-91e5282bf925",
      "content": {
        "id": "b9449e1b-1769-3ec1-b8a5-91e5282bf925",
        "contentType": "STORY",
        "title": "How Regeneron’s Broader Biologics Pipeline And Capital Return Focus At Regeneron Pharmaceuticals (REGN) Has Changed Its Investment Story",
        "description": "",
        "summary": "Regeneron Pharmaceuticals has recently drawn renewed attention as investment funds, Wall Street analysts, and industry observers highlight its broad biologics pipeline, disciplined capital allocation, and avoidance of large acquisitions, alongside ongoing initiatives such as its long-term US$100 million sponsorship of the Regeneron Science Talent Search. What stands out is how investors increasingly emphasize the value of Regeneron’s pipeline beyond flagship products, viewing its focus on...",
        "pubDate": "2026-01-23T10:12:43Z",
        "displayTime": "2026-01-23T10:12:43Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/a52f4d4b48157c0b8b51190845e3ba14",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/w30LARiR1Z35GusfaFi.2g--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/a52f4d4b48157c0b8b51190845e3ba14.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3eDp_RSETU8kXm3usDK_gQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/a52f4d4b48157c0b8b51190845e3ba14.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/regeneron-broader-biologics-pipeline-capital-101243662.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/regeneron-broader-biologics-pipeline-capital-101243662.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]